APO C300 Pill - white green capsule/oblong, 22mm
Pill with imprint APO C300 is White / Green, Capsule/Oblong and has been identified as Carbamazepine Extended-Release 300 mg. It is supplied by Apotex Corp.
Carbamazepine is used in the treatment of Trigeminal Neuralgia; Bipolar Disorder; Schizoaffective Disorder; Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO C300
Carbamazepine Extended-Release
- Imprint
- APO C300
- Strength
- 300 mg
- Color
- White / Green
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-2807
- Inactive Ingredients
-
ethylcellulose (7 mPa.s),
silicon dioxide,
stearic acid,
gelatin,
FD&C Blue No. 2,
ferric oxide yellow,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "APO C300"
More about carbamazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (346)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Carbamazepine drug information
- Carbamazepine (Intravenous) (Advanced Reading)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Tablets
- Carbamazepine Tablets
Other brands
Tegretol, Tegretol XR, Carbatrol, Epitol, ... +2 more
Professional resources
- Carbamazepine monograph
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
Other brands
Tegretol, Carbatrol, Epitol, Equetro, Carnexiv
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.